Holen Sie sich die Stockscreener-App
1.10
1.38%
0.01
Schlusskurs vom Vortag:
$1.09
Offen:
$1.1
24-Stunden-Volumen:
5,594
Relative Volume:
0.02
Marktkapitalisierung:
$98.67M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.15M
KGV:
-1.2088
EPS:
-0.91
Netto-Cashflow:
$-31.63M
1W Leistung:
-10.16%
1M Leistung:
+0.45%
6M Leistung:
+27.07%
1J Leistung:
-51.32%
1-Tages-Spanne:
$1.10
$1.12
1-Wochen-Bereich:
$1.052
$1.256
52-Wochen-Spanne:
$0.49
$2.3257
Context Therapeutics Inc Stock (CNTX) Company Profile
Firmenname
Context Therapeutics Inc
Sektor
Branche
Telefon
267-225-7416
Adresse
2001 MARKET STREET, PHILADELPHIA
Vergleichen Sie CNTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
1.10 | 101.37M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.98 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
653.27 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
828.70 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.54 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-04-21 | Eingeleitet | William Blair | Outperform |
| 2025-01-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-11-25 | Eingeleitet | D. Boral Capital | Buy |
| 2024-05-16 | Eingeleitet | Piper Sandler | Overweight |
Context Therapeutics Inc Aktie (CNTX) Neueste Nachrichten
Why analysts remain bullish on Context Therapeutics Inc. stockWall Street Watch & Intraday High Probability Alerts - newser.com
Is Context Therapeutics Inc. stock poised for growthInflation Watch & Weekly Stock Performance Updates - newser.com
Context Therapeutics Inc. stock trendline breakdownDividend Hike & Proven Capital Preservation Tips - newser.com
Does Context Therapeutics Inc. stock trade at a discount to peersWeekly Risk Report & AI Forecast for Swing Trade Picks - newser.com
Is Context Therapeutics Inc. a candidate for recovery playJuly 2025 Institutional & Weekly High Potential Stock Alerts - newser.com
Applying chart zones and confluence areas to Context Therapeutics Inc.July 2025 Review & Consistent Profit Trade Alerts - newser.com
Is Context Therapeutics Inc. stock a top pick in earnings seasonJuly 2025 Movers & Real-Time Volume Analysis - newser.com
Is Context Therapeutics Inc. stock a defensive play in 2025Treasury Yields & Weekly Chart Analysis and Trade Guides - newser.com
Is Context Therapeutics Inc. stock positioned well for digital economyJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Is Context Therapeutics Inc. trending in predictive chart modelsPortfolio Update Summary & Daily Stock Trend Watchlist - newser.com
Real time scanner hits for Context Therapeutics Inc. explained2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
What’s the recovery path for long term holders of Context Therapeutics Inc.Trade Performance Summary & Precise Swing Trade Alerts - newser.com
What recovery options are there for Context Therapeutics Inc.Portfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Is Context Therapeutics Inc. stock resilient to inflationWeekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com
Context Therapeutics Grants Stock Options to New Hire - MSN
How to interpret RSI for Context Therapeutics Inc. stockM&A Rumor & Weekly High Conviction Ideas - newser.com
Why hedge funds are buying Context Therapeutics Inc. stockEarnings Recap Summary & Precise Trade Entry Recommendations - newser.com
Exit strategy if you’re trapped in Context Therapeutics Inc.July 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
What drives Context Therapeutics Inc stock priceEnergy Sector Updates & Small Budget Trading Ideas - earlytimes.in
Context Therapeutics (CNTX) Projected to Post Earnings on Wednesday - MarketBeat
Statistical indicators supporting Context Therapeutics Inc.’s strengthTake Profit & Weekly High Potential Alerts - newser.com
Context Therapeutics Inc. (NASDAQ:CNTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer - GlobeNewswire Inc.
Context Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Context Therapeutics Inc-Aktie (CNTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Levit Alex C. | Chief Legal Officer, Corp. Sec |
Jun 06 '25 |
Buy |
0.58 |
20,000 |
11,520 |
29,000 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.64 |
40,010 |
25,486 |
80,010 |
0.37%
1.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):